Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01535248 · ClinicalTrials.gov registry record
Echo Detection of Endoscopic Retrograde Cholangiopancreatography (ERCP) Air Embolus
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 17
- Enrollment target
NCT01535248: Completed study, sponsored by University of Nebraska.
NCT01535248 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01535248 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
Endoscopic retrograde cholangiopancreatography (ERCP) is an endoscopy technique to visualize and evaluate the pancreatic and biliary systems. It has been reported that rare instances of air embolus have been found associated with the performance of an ERCP and many of these events are fatal. It is our proposal to use transthoracic echocardiography to continuously evaluate for the presence of intra-cardiac air secondary to ERCP venous air embolism and attempt to quantify the incidence of this complication and any potential patient factors that might increase the risk of this complication.
Primary Outcome
Patients who are scheduled for ERCP as part of their routine care will be assessed for the presence of air embolus, both clinically relevant (in the form of hemodynamic changes) and those situations where air is identified and does not appear to have a clinical effect. This is scheduled to occur over one day's time and only during the procedure are we planning on performing the echo for surveillance of air emboli.
Interventions
- OTHER Transthoracic Echocardiography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2012-03-07 |
| Est. Completion | 2015-12-30 |
What the finished NCT01535248 record still lists
NCT01535248 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Transthoracic Echocardiography is the first listed.
NCT01535248 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01535248 about?
NCT01535248 is a clinical study titled "Echo Detection of Endoscopic Retrograde Cholangiopancreatography (ERCP) Air Embolus". Endoscopic retrograde cholangiopancreatography (ERCP) is an endoscopy technique to visualize and evaluate the pancreatic and biliary systems. It has been reported that rare instances of air embolus have been found associated with the performance of an ERCP and many of these events are fatal. It is o...
What is the current status of trial NCT01535248?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2012-03-07. Estimated completion is 2015-12-30.
What interventions are being tested in trial NCT01535248?
The interventions under investigation include: Transthoracic Echocardiography (OTHER).
Who is sponsoring clinical trial NCT01535248?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI